Citations

Clear

439 citation(s) found for "Stone, M".

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis
Sreih, Antoine G. , Ezzedine, Rana, Leng, Lin , Yao, Jie , Reid, Duncan, Piecychna, Marta, Carette, Simon , Cuthbertson, David , Dellaripa, Paul F. , Hoffman, Gary S., Koening, Curry L. , Langford, Carol A. , Mahr, Alfred , McAlear, Carol A. , Maksimowicz‐McKinnon, Kathleen , Clair, E. William St. , Stone, John H. , Ytterberg, Steven R. , Edberg, Jeffrey C., Mahr, Alfred , Sreih, Antoine G , Fan, Juan , Khalidi, Nader , Monach, Paul A. , Seo, Philip , Specks, Ulrich , Merkel, Peter A. , Bucala, Richard

Mayo Clinic

Arthritis & Rheumatology | June 28, 2018 | Volume: 70 | Issue: 12 | Pages: 2077-2086

10.1002/art.40655 | PMID 29953750 Get It

ObjectiveTo examine the association between macrophage migration inhibitory factor (MIF) promoter polymorphisms and granulomatosis with polyangiitis (GPA) in human subjects, and to assess the role of MIF in a murine model of granulomatous vasculitis.MethodsThe human study involved 1,077 patients with GPA and healthy controls whose serum was genotyped by capillary electrophoresis for the MIF −794 CATT5−8 promoter microsatellite (rs5844572). MIF promoter, CATT‐length–dependent gene expression in response to β‐glucan was assessed by gene reporter assays. In mouse studies, granulomatous disease was induced by injection of Candida albicans β‐glucan into wild‐type (WT) or Mif‐knockout (Mif‐KO) C57BL/6 mice and C57BL/6 mice transgenically overexpressing Mif in lung epithelium (Mif lung–Tg2.1). Mice were treated with a neutralizing anti‐MIF antibody and analyzed for the density of pulmonary granulomas, expression of inflammatory chemokines, and frequency of mortality.ResultsThe percentage of human subjects carrying >5 CATT repeats in each MIF allele (high genotypic MIF expressers) was 60.2% among patients with GPA and 53.9% among healthy controls (adjusted P = 0.049). In response to granulomatous stimulation, human MIF gene expression increased proportionally with CATT length. Mif lung–Tg2.1 mice exhibited more pulmonary granulomas than WT mice, which in turn showed more granulomas than Mif‐KO mice. A significantly higher percentage of Mif lung–Tg2.1 mice, compared to Mif‐KO or WT mice, died when injected with Candida albicans β‐glucan, and treatment of these mice with an anti‐MIF monoclonal antibody protected against a lethal outcome. Levels of MIF‐dependent neutrophil/macrophage chemokines were elevated in the bronchoalveolar lavage fluid or plasma of Mif lung–Tg2.1 mice.ConclusionPatients with GPA have an increased frequency of high MIF expression CATT alleles. Higher Mif expression increases the incidence of mortality and pulmonary granulomas in Mif lung–Tg2.1 mice, while anti‐MIF treatment protects these mice against death. Blockade of MIF in high genotypic MIF expressers may therefore offer a selective pharmacologic therapy for GPA.
Stimulation Contractility Gradient of a Neuromuscular Choristoma Within the Sciatic Nerve: 2-Dimensional Operative Video
Stone, Jonathan J. , Amrami, Kimberly K. , Carter, Jodi M. , Spinner, Robert J. , Carter, Jodi

Mayo Clinic

Operative Neurosurgery | May 24, 2018 | Volume: 16 | Issue: 1 | Pages: E17-E17

10.1093/ons/opy131 | PMID 29800277 Get It

Abstract Neuromuscular choristoma (NMC) is a rare congenital nerve lesion that is classified by the presence of heterotopic muscle fibers intercalated within nerve fascicles. 1 The presence of NMC typically causes progressive neuropathy and bony/soft tissue undergrowth, often leading to a shortened atrophic limb. 2,3 The typical appearance of NMC on magnetic resonance imaging is an enlarged fusiform nerve that exhibits minimal gadolinium enhancement. 4 While there is increasing documentation of pathognomonic clinical and radiographic features for various diffuse fusiform peripheral nerve lesions, nerve biopsy is still occasionally required for some patients given the rarity of these diseases and progressive neuropathic features. The intraoperative appearance of NMC and its unique electrical stimulation properties are quite interesting. Intrafascicular replacement of nerve by skeletal muscle gives the nerve a red beefy color and causes the fascicles to contract with electrical stimulation. 5 In this video, we demonstrate the intraoperative appearance and contractile properties of NMC in a 60-yr-old woman with progressive sciatic neuropathy. Histologic and immunohistochemical studies identified a gradient of intralesional mature skeletal muscle within the NMC, with substantially fewer desmin-positive skeletal muscle fibers in the distal aspect. A gradient of contractility with intraoperative stimulation seemed to correlate with this pathology. These findings suggest that the lesional extent of NMC may not be clinically or grossly evident, reflecting a varying distribution of skeletal muscle within the affected nerve. The Mayo Clinic Institutional Review Board Office for Human Research Protection does not require approval for single participant case studies. The subject involved in this study was not identifiable and the general surgical consent form included permission for intraoperative photos and video.
Targeted nerve biopsy: A technique in evolution
Marek, Tomáš , Stone, Jonathan J. , Amrami, Kimberly K. , Spinner, Robert J.

Mayo Clinic

Clinical Anatomy | April 27, 2018 | Volume: 31 | Issue: 8 | Pages: 1200-1204

10.1002/ca.23195 | PMID 29700865 Get It

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Berti, Alvise , Warner, Roscoe L., Johnson, Kent J., Schroeder, Darrell R. , Kabat, Brian, Langford, Carol A. , Hoffman, Gary S., Fervenza, Fernanado C., Kallenberg, Cees G. M., Clair, E. William St. , Brunetta, Paul , Stone, John H. , Merkel, Peter A., Cornec, Divi, Schroeder, Darrell, Berti, Alvise , Schroeder, Darrell , Cornec, Divi , Fervenza, Fernanado, Seo, Philip , Spiera, Robert , Merkel, Peter A., Specks, Ulrich , Monach, Paul A.

Mayo Clinic

Arthritis & Rheumatology | April 25, 2018 | Volume: 70 | Issue: 7 | Pages: 1114-1121

10.1002/art.40471 | PMID 29693324 Get It

ObjectiveTo evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV), classified by antineutrophil cytoplasmic antibody (ANCA) specificity (proteinase 3 ANCA [PR3‐ANCA] versus myeloperoxidase ANCA [MPO‐ANCA]) or by clinical diagnosis (granulomatosis with polyangiitis [GPA] versus microscopic polyangiitis [MPA]).MethodsA panel of 29 cytokines was tested in 186 patients with active AAV at inclusion into the Rituximab in AAV trial. Cytokine concentrations were compared between groups within each classification system. Multivariable analyses adjusted for age, sex, and renal insufficiency were performed, with each biomarker as a dependent variable and ANCA specificity and clinical diagnosis as explanatory variables of interest.ResultsLevels of 9 circulating cytokines (interleukin‐6 [IL‐6], granulocyte–macrophage colony‐stimulating factor [GM‐CSF], IL‐15, IL‐18, CXCL8/IL‐8, CCL‐17/thymus and activation–regulated chemokine [TARC], IL‐18 binding protein [IL‐18 BP], soluble IL‐2 receptor α [sIL‐2Rα], and nerve growth factor β [NGFβ]) were significantly higher in PR3‐AAV than MPO‐AAV, 4 cytokines (sIL6R, soluble tumor necrosis factor receptor type II [sTNFRII], neutrophil gelatinase–associated lipocalin [NGAL], and soluble intercellular adhesion molecule 1 [sICAM‐1]) were higher in MPO‐AAV than in PR3‐AAV, 6 cytokines (IL‐6, GM‐CSF, IL‐15, IL‐18, sIL‐2Rα, and NGFβ) were higher in GPA than in MPA, and 3 cytokines (osteopontin, sTNFRII, and NGAL) were higher in MPA than in GPA (all P < 0.05). For nearly all cytokines, the difference between PR3‐AAV and MPO‐AAV was larger than that between GPA and MPA. The multivariate analysis showed that 8 cytokines (IL‐15, IL‐8, IL‐18 BP, NGF‐β, sICAM‐1, TARC, osteopontin, and kidney injury molecule 1 (P < 0.05) distinguished patients with AAV better (lower P values and larger effect sizes) when grouped by ANCA specificity than by clinical diagnosis.ConclusionDistinct cytokine profiles were identified for PR3‐AAV versus MPO‐AAV and for GPA versus MPA. Differences in these circulating immune mediators are more strongly associated with ANCA specificity than with clinical diagnosis, suggesting that heterogeneity in the AAV subtypes extends beyond clinical phenotypes.
Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey
Stahl, Maximilian , Pine, Alexander B. , Litzow, Mark R. , Luger, Selina M. , Stone, Richard M. , Kim, Tae Kon , Sekeres, Mikkael A. , Komrokji, Rami S. , Gore, Steven D. , Zeidan, Amer M. , Litzow, Mark R. , Komrokji, Rami S , Sekeres, Mikkael A , Kim, Tae Kon , Hendrickson, Jeanne E. , Erba, Harry Paul , Steensma, David P. , Zeidan, Amer M

Mayo Clinic

Leukemia & Lymphoma | April 18, 2018 | Volume: 59 | Issue: 11 | Pages: 2723-2726

10.1080/10428194.2018.1452219 | PMID 29667455 Get It

B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease
Redfors, Björn , Crowley, Aaron , Ben‐Yehuda, Ori , Lembo, Nicholas , Brown, W. Morris, Banning, Adrian , Sabik, Joseph F. , Stone, Gregg W. , Serruys, Patrick W , Chen, Shmuel , Gersh, Bernard J. , Taggart, David P , Serruys, Patrick W. , Kappetein, A. Pieter , Banning, Adrian

Mayo Clinic

Circulation | April 17, 2018 | Volume: 138 | Issue: 5 | Pages: 469-478

10.1161/circulationaha.118.033631 | PMID 29666071 Get It

Background: Elevated B-type natriuretic peptide (BNP) is reflective of impaired cardiac function and is associated with worse prognosis among patients with coronary artery disease (CAD). We sought to assess the association between baseline BNP, adverse outcomes, and the relative efficacy of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with left main CAD. Methods: The EXCEL trial (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) randomized patients with left main CAD and low or intermediate SYNTAX scores (Synergy Between PCI With TAXUS and Cardiac Surgery) to PCI with everolimus-eluting stents versus CABG. The primary end point was the composite of all-cause death, myocardial infarction, or stroke. We used multivariable Cox proportional hazards regression to assess the associations between normal versus elevated BNP (≥100 pg/mL), randomized treatment, and the 3-year risk of adverse events. Results: BNP at baseline was elevated in 410 of 1037 (39.5%) patients enrolled in EXCEL. Patients with elevated BNP levels were older and more frequently had additional cardiovascular risk factors and lower left ventricular ejection fraction than those with normal BNP, but had similar SYNTAX scores. Patients with elevated BNP had significantly higher 3-year rates of the primary end point (18.6% versus 11.7%; adjusted hazard ratio [HR], 1.62; 95% confidence interval [CI], 1.16–2.28; P =0.005) and higher mortality (11.5% versus 3.9%; adjusted HR, 2.49; 95% CI, 1.48–4.19; P =0.0006), both from cardiovascular and noncardiovascular causes. In contrast, there were no significant differences in the risks of myocardial infarction, stroke, ischemia-driven revascularization, stent thrombosis, graft occlusion, or major bleeding. A significant interaction ( P interaction =0.03) was present between elevated versus normal BNP and treatment with PCI versus CABG for the adjusted risk of the primary composite end point at 3 years among patients with elevated BNP (adjusted HR for PCI versus CABG, 1.54; 95% CI, 0.96–2.47) versus normal BNP (adjusted HR, 0.74; 95% CI, 0.46–1.20). This interaction was stronger when log(BNP) was modeled as a continuous variable ( P interaction =0.002). Conclusions: In the EXCEL trial, elevated baseline BNP levels in patients with left main CAD undergoing revascularization were independently associated with long-term mortality but not nonfatal adverse ischemic or bleeding events. The relative long-term outcomes after PCI versus CABG for revascularization of left main CAD may be conditioned by the baseline BNP level. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01205776.
An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index
Wallace, Zachary S. , Khosroshahi, Arezou , Carruthers, Mollie D., Perugino, Cory A. , Campochiaro, Corrado , Culver, Emma , Cortazar, Frank B. , Ebbo, Mikaël , Fernandes, Ana D. , Frulloni, Luca , Hart, Phil A. , Karadağ, Ömer , Kawa, Shigeyuki , Kim, Myung‐Hwan , Lanzillotta, Marco , Matsui, Shoko , Okazaki, Kazuichi , Ryu, Jay H. , Saeki, Takako , Schleinitz, N. , Tanasa, Paula, Umehara, Hisanori , Webster, George, Stone, John H. , Ryu, Jay H , Carruthers, Mollie D., Choi, Hyon K. , Della‐Torre, Emanuel , Kawano, Mitsuhiro , Zhang, Wen , Campochiaro, Corrado

Mayo Clinic

Arthritis Care & Research | February 18, 2018 | Volume: 70 | Issue: 11 | Pages: 1671-1678

10.1002/acr.23543 | PMID 29457382 Get It

ObjectiveIgG4‐related disease (IgG4‐RD) can cause fibroinflammatory lesions in nearly any organ, leading to organ dysfunction and failure. The IgG4‐RD Responder Index (RI) was developed to help investigators assess the efficacy of treatment in a structured manner. The aim of this study was to validate the RI in a multinational investigation.MethodsThe RI guides investigators through assessments of disease activity and damage in 25 domains, incorporating higher weights for disease manifestations that require urgent treatment or that worsen despite treatment. After a training exercise, investigators reviewed 12 written IgG4‐RD vignettes based on real patients. Investigators calculated both an RI score as well as a physician's global assessment (PhGA) score for each vignette. In a longitudinal assessment, 3 investigators used the RI in 15 patients with newly active disease who were followed up over serial visits after treatment. We assessed interrater and intrarater reliability, precision, validity, and responsiveness.ResultsThe 26 physician investigators included representatives from 6 specialties and 9 countries. The interrater and intrarater reliability of the RI was strong (0.89 and 0.69, respectively). Correlations (construct validity) between the RI and PhGA were high (Spearman's r = 0.9, P < 0.0001). The RI was sensitive to change (discriminant validity). Following treatment, there was significant improvement in the RI score (mean change 10.5 [95% confidence interval (95% CI) 5.4–12], P < 0.001), which correlated with the change in the PhGA. Urgent disease and damage were captured effectively.DiscussionIn this international, multispecialty study, we observed that the RI is a valid and reliable disease activity assessment tool that can be used to measure response to therapy.
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
Ngankeu, Apollinaire, Ranganathan, Parvathi , Havelange, Violaine , Volinia, Stefano , Powell, Bayard L., Kolitz, Jonathan E. , Uy, Geoffrey L. , Stone, Richard M. , Bloomfield, Clara D. , Garzon, Ramiro , Nicolet, Deedra , Kornblau, Steven M. , Andreeff, Michael , Croce, Carlo Maria , Uy, Geoffrey

Mayo Clinic

Oncotarget | December 12, 2017 | Volume: 9 | Issue: 4 | Pages: 4354-4365

10.18632/oncotarget.23150 | PMID 29435107 Get It

Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness
Popkirov, Stoyan , Staab, Jeffrey P. , Stone, Jon , Staab, Jeffrey P

Mayo Clinic

Practical Neurology | December 5, 2017 | Volume: 18 | Issue: 1 | Pages: 5-13

10.1136/practneurol-2017-001809 | PMID 29208729 Get It

Persistent postural-perceptual dizziness (PPPD) is a newly defined diagnostic syndrome that unifies key features of chronic subjective dizziness, phobic postural vertigo and related disorders. It describes a common chronic dysfunction of the vestibular system and brain that produces persistent dizziness, non-spinning vertigo and/or unsteadiness. The disorder constitutes a long-term maladaptation to a neuro-otological, medical or psychological event that triggered vestibular symptoms, and is usefully considered within the spectrum of other functional neurological disorders. While diagnostic tests and conventional imaging usually remain negative, patients with PPPD present in a characteristic way that maps on to positive diagnostic criteria. Patients often develop secondary functional gait disorder, anxiety, avoidance behaviour and severe disability. Once recognised, PPPD can be managed with effective communication and tailored treatment strategies, including specialised physical therapy (vestibular rehabilitation), serotonergic medications and cognitive-behavioural therapy.